Trial Profile
A Study to Evaluate the Risk of Serious Adverse Events following DTaP-IPV Vaccination.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs DTaP poliovirus vaccine (Primary)
- Indications Diphtheria; Pertussis; Poliomyelitis; Tetanus
- Focus Adverse reactions
- 05 Dec 2015 New trial record